The Increasing Prevalence of Dental and Orthopedic Issues in the World Is Boosting the Growth of the Global Hydroxyapatite Market
Hydroxyapatite Market |
Hydroxyapatite Market, By Type (Nano-sized, Micro-sized, Greater than Micrometers), By Application (Dental Care, Plastic Surgery, Orthopedic, Other Applications (Including Non- medical Applications)), By Geography (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa)- Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030.
Market Overview:
Hydroxyapatite (HA) is a naturally occurring mineral form of calcium apatite. It is a crystalline substance with the chemical formula Ca10(PO4)6(OH)2. Hydroxyapatite is the main inorganic component of bones and teeth, making up approximately 70% of the weight of human bones and providing them with strength and rigidity.
Hydroxyapatite has a unique structure that closely resembles the mineral component of bone tissue. It is composed of calcium ions (Ca2+) and phosphate ions (PO43-) arranged in a hexagonal lattice. The presence of hydroxyl ions (OH-) in its chemical composition distinguishes it from other forms of calcium apatite.
The Hydroxyapatite Market size is estimated to be valued at US$ 2,250.19 Million in 2022 and is expected to exhibit a CAGR of 6.52% between 2023 and 2030.
Competitive Landscape:
Major players operating in the global hydroxyapatite market include Zimmer Biomet, Taihei Chemical Industrial Co. Ltd, SigmaGraft Biomaterials, SANGI CO. LTD, HOYA Technosurgical Corporation (HOYA Corporation), Granulab Sdn. Bhd. (KPower Berhad), FLUIDINOVA, CGbio, Bio-Rad Laboratories Inc., Berkeley Advanced Biomaterials (GNI Group Ltd), and APS Materials Inc.
Key Market Drivers:
The rising prevalence of orthopedic and dental disorders, coupled with the growing geriatric population, is expected to augment the growth of the global hydroxyapatite market. HA's excellent biocompatibility and ability to promote bone regeneration make it an ideal material for implants, coatings, and fillers.
Extensive research and development activities in the field of biomaterials and tissue engineering have led to advancements in hydroxyapatite-based products. Ongoing research focuses on enhancing the properties and performance of hydroxyapatite, further driving market growth.
The increasing number of orthopedic surgeries, such as joint replacements and spinal fusion procedures, is boosting the demand for hydroxyapatite-based implants. HA coatings on metal implants improve osseointegration, leading to better clinical outcomes and reduced implant failure rates.
With improving economic conditions and increasing healthcare spending, particularly in emerging economies, the demand for advanced medical treatments and devices, including hydroxyapatite-based products, is on the rise. This is estimated to enhance the growth of the global hydroxyapatite. For instance, in March 2022, Cgbio and Shanghai Sanyou Medical signed a five-year export contract for BONGROS for around US$ 27 million.
Covid-19 Impact Analysis:
The urgent need for medical supplies during the COVID-19 pandemic led to increased demand for hydroxyapatite-based products used in diagnostics, drug delivery systems, and vaccine development. The focus on improving healthcare infrastructure and preparedness also boosted the market. This boosted the growth of the global market. For instance, in April 2021, FLUIDINOVA initiated a new project called FLUIDINOVA - Innovation in Nanocrystalline Hydroxyapatite Offering Synthetics and Industrial/ Organizational Processes.
Key Takeaways:
· North America is expected to dominate the growth of the global market, owing to the presence of a well-established healthcare infrastructure, a high prevalence of orthopedic and dental disorders, and significant investments in research and development activities. The United States and Canada are the key contributors to the regional market growth. For instance, in March 2022, Zimmer Biomet Holdings Inc. completed its spinoff of ZimVie, which is the former spine and dental business of Zimmer Biomet.
· The Asia-Pacific region is estimated to witness high growth in the global market, owing to the rising healthcare expenditure, growing population, and increasing awareness about advanced medical treatments. China, Japan, and India are the key markets in this region. For instance, in March 2022, Cgbio signed an export contract with Kerunxi Medical for five years.
Comments
Post a Comment